Navigation Links
Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference
Date:2/7/2013

HAYWARD, Calif., Feb. 7, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced Paul F. Truex , Anthera's President and Chief Executive Officer, will present at the 2013 Leerink Global Healthcare Conference in New York, NY on Thursday, February 14, 2013 at approximately 8:00 am Eastern Time.

2013 Leerink Global Healthcare Conference Presentation
Date/Time: Thursday, February 14, at 8:00 am Eastern Time
Location: The Waldorf Astoria New York

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune diseases.

CONTACT: Bianca Nery of Anthera Pharmaceuticals, Inc., bnery@anthera.com or 510.856.5586.


'/>"/>
SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
2. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
3. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
4. Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
5. Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting
6. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
7. Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE)
8. Anthera Pharmaceuticals Reports 2012 Second Quarter Financial Results And Provides Clinical Progress Update
9. Anthera Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
10. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
11. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)...  QT Vascular Ltd., together with its subsidiaries ... its subsidiaries, the "Group"), a global company engaged ... therapeutic solutions for the minimally invasive treatment of ... the below-the-knee ("BTK") cohort of patients in the ... on August 15, 2015 at the 5th Annual ...
(Date:8/30/2015)... August 31, 2015 Noser ... to deliver new ... first citizen-owned health data transaction platform, announced today strategic ... to engineer and bring to market its global ... , "Our business model is built on ...
(Date:8/28/2015)... 2015  Delays in the launch and execution ... the decision-making process, resulting in missed opportunities and ... biopharmaceutical companies to develop a tactical approach to ... and more meaningful insights. According ... three-quarters of benchmarked study participants use review cycle ...
Breaking Medicine Technology:Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 2healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 3healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 4Expediting the Pharmaceutical Market Research Process for Faster Insights 2
... 25 Accuray Incorporated (Nasdaq: ARAY ), a ... it will report results for its first quarter of fiscal ... after the market closes. A conference call to ... ET and will be hosted by Euan S. Thomson, Ph.D., ...
... NEW YORK, Oct. 25 See video from ... New Phase III data indicate ... Y conjugate vaccine) demonstrated robust immunogenicity in infants ... meningococcal disease 1, 3. These data were presented ...
Cached Medicine Technology:Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2011 2
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Finnleo ... line of saunas. Available starting in the 3rd quarter, the newly re-styled and re-designed ... quickly without special tools. , These new models include more glass and a more ...
(Date:8/31/2015)... , ... August 31, 2015 , ... The more hours ... a higher body mass index and bigger waist circumference, a 15-year analysis by the ... did not hold in later years, indicating that young adulthood is an important time ...
(Date:8/31/2015)... ... 2015 , ... On Saturday, May 30th, 2015, Best Drug Rehabilitation sponsored a ... Mendon, IL. The purpose behind this concert was to raise money for music education ... Drug Rehabilitation’s sponsorship of “Music with a Mission” helped with a portion of the ...
(Date:8/31/2015)... ... 31, 2015 , ... "While working as an anesthesiologist, I ... oxygen with a lower risk of failure," explained an inventor, from Dearborn Heights, ... Device." , The Adam Device offers a quick, effective and predictable way to ...
(Date:8/31/2015)... ... 31, 2015 , ... Westchester Insurance, a full service insurance ... with the Tarrant County chapter of Meals on Wheels to provide healthy meals ... and largest national organization that supports the more than five thousand nutrition programs ...
Breaking Medicine News(10 mins):Health News:Finnleo Introduces Hallmark Series Saunas 2Health News:Watching More TV as a Young Adult Predicts Obesity 2Health News:Watching More TV as a Young Adult Predicts Obesity 3Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3Health News:InventHelp® Client's Invents Medical Device to Restore Respiratory Function (BGF-905) 2Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 2Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 3
... Drug Administration announced that Vioxx - Merck's blockbuster painkiller, ... said that Merck can claim that Vioxx has fewer ... But the FDA also decided that the Vioxx label ... increased risk of heart attack or high blood pressure. ...
... study, Vitamin C and E supplements protect the coronary ... be a life-saver// but, the vessels linking the new ... only a way could be found of blocking this ... Hopkins Hospital in Boston, US, believe that they have ...
... is a chronic neurological disorder in which misfiring electrical ... million Americans have epilepsy, and more than a million ... a significant risk that their children will have problems ... new study adds to growing evidence that many commonly ...
... Carolina at Chapel Hill, state about the discovery of how ... The UNC scientists have found a previously unknown ... the genetic messenger known as RNA. When the chemical ... which the information contained in DNA,is converted into functions critical ...
... to munching his way through 50 ballpoint pens a week has ... a month on his habit after he was banned// from using ... to write with. “My manager took me one side ... but the fact that nobody else could ever find a pen ...
... their daily exercise time in order to control their weight. ... day// of moderate exercise for health and weight control. But ... that this may not be enough. ,They have ... gain weight. Physical inactivity alone accounted for 60 per cent ...
Cached Medicine News:
... In interventional cardiology, accurate ... role, particularly in determining the ... With Interventional Cardiac 3-D (IC3D), ... imaging tool, clinicians are now ...
... versatile solution designed to optimize the workflow ... to diagnosis and therapy, for both diagnostic ... your cath lab becomes an integral part ... free to concentrate on what really matters: ...
... Artis FC is a floor-mounted, ... flexible system architecture for vascular ... The flexible and ergonomic system ... adapt the system configuration to ...
The ACUSON Sequoia C512 system elevates imaging and Doppler performance through new, high-density acoustic sampling, precise control of the transmitted acoustic waveform, and new transducer technolog...
Medicine Products: